High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study

• Autors principals: Bing Zhao (Autor), Min Liu (Autor), Ping Liu (Autor), Yibing Peng (Autor), Jun Huang (Autor), Mengjiao Li (Autor), Yihui Wang (Autor), LiLi Xu (Autor), Silei Sun (Autor), Xing Qi (Autor), Yun Ling (Autor), Jian Li (Autor), Wenhong Zhang (Autor), Enqiang Mao (Autor), Jieming Qu (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Coronavirus disease 2019 (COVID-19) pandemic is continuing to impact multiple countries worldwide and effective treatment options are still being developed. In this study, we investigate the potential of high-dose intravenous vitamin C (HDIVC) in the prevention of moderate COVID-19 disea...